Business By Shannon Thaler Published November 1, 2023, 12:10 p.m. ET Growing demand for Ozempic and Wegovy, made by Novo Nordisk, has fueled a rise in illegal sales of weight-loss drugs in Denmark, where the pharmaceutical company is based, the Danish Medicines Agency reported. The agency said in a statement… Continue Reading Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs
Growing demand for Ozempic and Wegovy, made by Novo Nordisk, has fueled a rise in illegal sales of weight-loss drugs in Denmark, where the pharmaceutical company is based, the Danish Medicines Agency reported. The agency said in a statement released Tuesday that authorities are aware of 26 websites illegally selling… Continue Reading Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs
Eye-popping predictions for weight-loss drug sales hinge on insurance companies agreeing to provide coverage for expensive treatments, and momentum appears to be building on that front. But Allen Lutz, an analyst at Bank of America, wonders if employers know how risky the bet they’re making is. The hope is that… Continue Reading Bank of America Sees Risks for Employers as Insurance Coverage of Weight Loss Drugs Increases